Abstract:Objective To evaluate the effect of sildenafil on the expression of hexokinase-2 (HK-2) in lung tissues in a rat model of pulmonary arterial hypertension. Methods Thirty-two male Sprague-Dawley rats, aged 2 months, weighing 200-220 g, were allocated into 4 groups with 8 rats in each group using a random number table: control group ( group C), pulmonary arterial hypertension group ( group PAH), low-dose sildenafil group (group S1 ) and high-dose sildenafil group (group S2 ). The model of pul-monary arterial hypertension was established through combining left pneumonectomy with subcutaneous in-jection of 60 mg∕kg monocrotaline. Two percent sildenafil 30 and 50 mg∕kg were administered by intragastric gavage once a day for 3 consecutive weeks starting from 5 weeks after pneumonectomy in S1 and S2 groups, respectively. The chest was opened after the end of administration for measurement of mean pulmonary arte-rial pressure (mPAP) and right ventricular systolic pressure (RVSP). The hearts and lungs were excised for determination of the percentage of the thickness of tunica media of pulmonary arterioles, size of right ventricular cardiomyocytes, α-smooth muscle actin (α-SMA) expression (by immunohistochemistry) and expression of hypoxia-inducible factor-1α (HIF-1α) and HK-2 ( by Western blot). Results Compared with group C, the mPAP, RVSP and percentage of MT were significantly increased, the size of right ven-tricular cardiomyocytes was enlarged, and the expression of HIF-1α, HK-2 and α-SMA was up-regulated in PAH and S1 groups, and the RVSP and percentage of MT were significantly increased, the size of right ventricular cardiomyocytes was enlarged, and the expression of HIF-1α, HK-2 and α-SMA was up-regula-ted (P<0. 05), and no significant change was found in mPAP in group S2 (P>0. 05). Compared with group PAH, the percentage of MT was significantly decreased, the size of right ventricular cardiomyocytes was decreased, and the expression of HIF-1α, HK-2 and α-SMA was down-regulated in group S1 , and the mPAP, RVSP and percentage of MT were significantly decreased, the size of right ventricular cardiomyo-cytes was decreased, and the expression of HIF-1α, HK-2 and α-SMA was down-regulated in group S2 (P<0. 05). Conclusion The mechanism by which sildenafil inhibits proliferation of pulmonary vascular smooth muscle cells is related to inhibiting the expression of HK-2 in lung tissues in a rat model of pulmona-ry arterial hypertension.

Sildenafil Inhibits Chronically Hypoxic Upregulation of Canonical Transient Receptor Potential Expression in Rat Pulmonary Arterial Smooth Muscle.

Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.

Sildenefil Increases Connexin 40 in Smooth Muscle Cells Through Activation of BMP Pathways in Pulmonary Arterial Hypertension.

Sildenafil Up-Regulates Kv1.5 Mrna Expression in Rats with Pulmonary Hypertension

Chronic Hypoxia Promoted Pulmonary Arterial Smooth Muscle Cells Proliferation Through Upregulated Calcium‐sensing Receptorcanonical Transient Receptor Potential 1/6 Pathway

Sildenafil protects against pulmonary hypertension induced by hypoxia in neonatal rats via activation of PPARγ‑mediated downregulation of TRPC

Sildenafil attenuates hypoxic pulmonary remodelling by inhibiting bone marrow progenitor cells

Effect of Sildenafil on Expression of Hexokinase-2 in Lung Tissues in a Rat Model of Hypertension, Pul-Monary

Sildenafil Improves Pulmonary Vascular Remodeling in a Rat Model of Persistent Pulmonary Hypertension of the Newborn

Effects of Sildenafil on Pulmonary Vascular Remodeling in a Rat Model of Pulmonary Hypertension

Sildenafil Potentiates Bone Morphogenetic Protein Signaling in Pulmonary Arterial Smooth Muscle Cells and in Experimental Pulmonary Hypertension

Involvement of Calcium-Sensing Receptors in Hypoxia-Induced Vascular Remodeling and Pulmonary Hypertension by Promoting Phenotypic Modulation of Small Pulmonary Arteries

The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.

Sildenafil inhibits calcineurin/NFATc2-mediated cyclin A expression in pulmonary artery smooth muscle cells.

Chronic Hypoxia-Induced Upregulation Of Ca2+-Activated Cl- Channel In Pulmonary Arterial Myocytes: A Mechanism Contributing To Enhanced Vasoreactivity

Hypoxia Selectively Upregulates Cation Channels and Increases Cytosolic [ca2+] in Pulmonary, but Not Coronary, Arterial Smooth Muscle Cells

Orai1, 2, 3 and STIM1 Promote Store-Operated Calcium Entry in Pulmonary Arterial Smooth Muscle Cells

Transient Receptor Potential Melastatin-8 Activation Induces Relaxation of Pulmonary Artery by Inhibition of Store-Operated Calcium Entry in Normoxic and Chronic Hypoxic Pulmonary Hypertensive Rats

Sildenafil decreases rat tracheal hyperresponsiveness to carbachol and changes canonical transient receptor potential gene expression after antigen challenge

Sildenafil improves the function of endothelial cells in patients suffering from congenital heart disease with pulmonary hypertension

Sildenafil Potentiates the Proliferative Effect of Porcine Pulmonary Artery Smooth Muscle Cells Induced by Serotonin in Vitro.